nodes	percent_of_prediction	percent_of_DWPC	metapath
Methohexital—Cardio-respiratory arrest—Irbesartan—type 2 diabetes mellitus	0.02	0.0236	CcSEcCtD
Methohexital—Delirium—Glimepiride—type 2 diabetes mellitus	0.0142	0.0168	CcSEcCtD
Methohexital—Delirium—Bromocriptine—type 2 diabetes mellitus	0.0128	0.0151	CcSEcCtD
Methohexital—Liver function test abnormal—Acarbose—type 2 diabetes mellitus	0.0127	0.015	CcSEcCtD
Methohexital—Delirium—Gliclazide—type 2 diabetes mellitus	0.0105	0.0124	CcSEcCtD
Methohexital—Erythema—Tolbutamide—type 2 diabetes mellitus	0.00947	0.0112	CcSEcCtD
Methohexital—Salivary hypersecretion—Gliclazide—type 2 diabetes mellitus	0.00877	0.0104	CcSEcCtD
Methohexital—Erythema—Tolazamide—type 2 diabetes mellitus	0.00861	0.0102	CcSEcCtD
Methohexital—Liver function test abnormal—Pioglitazone—type 2 diabetes mellitus	0.00839	0.00992	CcSEcCtD
Methohexital—Erythema—Acarbose—type 2 diabetes mellitus	0.00827	0.00978	CcSEcCtD
Methohexital—Rhinitis—Repaglinide—type 2 diabetes mellitus	0.00795	0.0094	CcSEcCtD
Methohexital—Laryngospasm—Ramipril—type 2 diabetes mellitus	0.00771	0.00911	CcSEcCtD
Methohexital—Thrombophlebitis—Gliclazide—type 2 diabetes mellitus	0.00757	0.00895	CcSEcCtD
Methohexital—Gastrointestinal pain—Miglitol—type 2 diabetes mellitus	0.00703	0.0083	CcSEcCtD
Methohexital—Anaphylactic shock—Linagliptin—type 2 diabetes mellitus	0.00696	0.00822	CcSEcCtD
Methohexital—Erythema—Repaglinide—type 2 diabetes mellitus	0.00691	0.00816	CcSEcCtD
Methohexital—Abdominal pain—Miglitol—type 2 diabetes mellitus	0.00679	0.00803	CcSEcCtD
Methohexital—Rhinitis—Glipizide—type 2 diabetes mellitus	0.00658	0.00778	CcSEcCtD
Methohexital—Urticaria—Tolbutamide—type 2 diabetes mellitus	0.00614	0.00725	CcSEcCtD
Methohexital—Erythema—Glipizide—type 2 diabetes mellitus	0.00571	0.00675	CcSEcCtD
Methohexital—Anaphylactic shock—Repaglinide—type 2 diabetes mellitus	0.00564	0.00666	CcSEcCtD
Methohexital—Salivary hypersecretion—Ramipril—type 2 diabetes mellitus	0.00559	0.0066	CcSEcCtD
Methohexital—Urticaria—Chlorpropamide—type 2 diabetes mellitus	0.00558	0.0066	CcSEcCtD
Methohexital—Urticaria—Tolazamide—type 2 diabetes mellitus	0.00558	0.0066	CcSEcCtD
Methohexital—Rhinitis—Bromocriptine—type 2 diabetes mellitus	0.00554	0.00655	CcSEcCtD
Methohexital—Urticaria—Linagliptin—type 2 diabetes mellitus	0.00553	0.00653	CcSEcCtD
Methohexital—Gastrointestinal pain—Acarbose—type 2 diabetes mellitus	0.00552	0.00653	CcSEcCtD
Methohexital—Pruritus—Tolbutamide—type 2 diabetes mellitus	0.00547	0.00646	CcSEcCtD
Methohexital—Thiamylal—KCNJ11—type 2 diabetes mellitus	0.00546	0.633	CrCbGaD
Methohexital—Urticaria—Acarbose—type 2 diabetes mellitus	0.00536	0.00634	CcSEcCtD
Methohexital—Abdominal pain—Acarbose—type 2 diabetes mellitus	0.00534	0.00631	CcSEcCtD
Methohexital—Erythema—Glimepiride—type 2 diabetes mellitus	0.00533	0.0063	CcSEcCtD
Methohexital—Anaphylactic shock—Rosiglitazone—type 2 diabetes mellitus	0.00533	0.0063	CcSEcCtD
Methohexital—Gastrointestinal pain—Nateglinide—type 2 diabetes mellitus	0.00532	0.00629	CcSEcCtD
Methohexital—Urticaria—Nateglinide—type 2 diabetes mellitus	0.00517	0.00611	CcSEcCtD
Methohexital—Abdominal pain—Nateglinide—type 2 diabetes mellitus	0.00515	0.00608	CcSEcCtD
Methohexital—Nausea—Miglitol—type 2 diabetes mellitus	0.0051	0.00603	CcSEcCtD
Methohexital—Liver function test abnormal—Metformin—type 2 diabetes mellitus	0.00506	0.00598	CcSEcCtD
Methohexital—Bronchospasm—Orlistat—type 2 diabetes mellitus	0.00506	0.00598	CcSEcCtD
Methohexital—Pruritus—Tolazamide—type 2 diabetes mellitus	0.00497	0.00588	CcSEcCtD
Methohexital—Pruritus—Chlorpropamide—type 2 diabetes mellitus	0.00497	0.00588	CcSEcCtD
Methohexital—Agitation—Glimepiride—type 2 diabetes mellitus	0.0049	0.00579	CcSEcCtD
Methohexital—Anxiety—Glipizide—type 2 diabetes mellitus	0.00485	0.00573	CcSEcCtD
Methohexital—Headache—Tolbutamide—type 2 diabetes mellitus	0.00484	0.00572	CcSEcCtD
Methohexital—Liver function test abnormal—Irbesartan—type 2 diabetes mellitus	0.00478	0.00565	CcSEcCtD
Methohexital—Convulsion—Glimepiride—type 2 diabetes mellitus	0.00462	0.00546	CcSEcCtD
Methohexital—Gastrointestinal pain—Repaglinide—type 2 diabetes mellitus	0.00461	0.00545	CcSEcCtD
Methohexital—Pruritus—Nateglinide—type 2 diabetes mellitus	0.00461	0.00544	CcSEcCtD
Methohexital—Nausea—Tolbutamide—type 2 diabetes mellitus	0.00459	0.00542	CcSEcCtD
Methohexital—Shock—Glipizide—type 2 diabetes mellitus	0.00459	0.00542	CcSEcCtD
Methohexital—Rhinitis—Gliclazide—type 2 diabetes mellitus	0.00455	0.00537	CcSEcCtD
Methohexital—Anxiety—Glimepiride—type 2 diabetes mellitus	0.00452	0.00535	CcSEcCtD
Methohexital—Anxiety—Sitagliptin—type 2 diabetes mellitus	0.00451	0.00533	CcSEcCtD
Methohexital—Urticaria—Repaglinide—type 2 diabetes mellitus	0.00448	0.00529	CcSEcCtD
Methohexital—Vomiting—Chlorpropamide—type 2 diabetes mellitus	0.00447	0.00528	CcSEcCtD
Methohexital—Anaphylactic shock—Pioglitazone—type 2 diabetes mellitus	0.00447	0.00528	CcSEcCtD
Methohexital—Abdominal pain—Repaglinide—type 2 diabetes mellitus	0.00446	0.00527	CcSEcCtD
Methohexital—Agitation—Bromocriptine—type 2 diabetes mellitus	0.00442	0.00522	CcSEcCtD
Methohexital—Headache—Chlorpropamide—type 2 diabetes mellitus	0.0044	0.0052	CcSEcCtD
Methohexital—Headache—Tolazamide—type 2 diabetes mellitus	0.0044	0.0052	CcSEcCtD
Methohexital—Erythema—Glyburide—type 2 diabetes mellitus	0.0044	0.0052	CcSEcCtD
Methohexital—Headache—Linagliptin—type 2 diabetes mellitus	0.00436	0.00515	CcSEcCtD
Methohexital—Anaphylactic shock—Glimepiride—type 2 diabetes mellitus	0.00435	0.00514	CcSEcCtD
Methohexital—Anaphylactic shock—Sitagliptin—type 2 diabetes mellitus	0.00434	0.00513	CcSEcCtD
Methohexital—Vomiting—Acarbose—type 2 diabetes mellitus	0.00429	0.00507	CcSEcCtD
Methohexital—Shock—Glimepiride—type 2 diabetes mellitus	0.00428	0.00506	CcSEcCtD
Methohexital—Tachycardia—Glimepiride—type 2 diabetes mellitus	0.00425	0.00502	CcSEcCtD
Methohexital—Urticaria—Rosiglitazone—type 2 diabetes mellitus	0.00423	0.005	CcSEcCtD
Methohexital—Rhinitis—Valsartan—type 2 diabetes mellitus	0.00418	0.00494	CcSEcCtD
Methohexital—Nausea—Tolazamide—type 2 diabetes mellitus	0.00418	0.00493	CcSEcCtD
Methohexital—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.00418	0.00493	CcSEcCtD
Methohexital—Convulsion—Bromocriptine—type 2 diabetes mellitus	0.00417	0.00493	CcSEcCtD
Methohexital—Dyspnoea—Glipizide—type 2 diabetes mellitus	0.00416	0.00491	CcSEcCtD
Methohexital—Vomiting—Nateglinide—type 2 diabetes mellitus	0.00414	0.00489	CcSEcCtD
Methohexital—Anxiety—Bromocriptine—type 2 diabetes mellitus	0.00408	0.00482	CcSEcCtD
Methohexital—Hypotension—Glimepiride—type 2 diabetes mellitus	0.00407	0.00481	CcSEcCtD
Methohexital—Nausea—Acarbose—type 2 diabetes mellitus	0.00401	0.00474	CcSEcCtD
Methohexital—Pruritus—Repaglinide—type 2 diabetes mellitus	0.00399	0.00471	CcSEcCtD
Methohexital—Dyspnoea—Pioglitazone—type 2 diabetes mellitus	0.00398	0.00471	CcSEcCtD
Methohexital—Erythema—Gliclazide—type 2 diabetes mellitus	0.00395	0.00467	CcSEcCtD
Methohexital—Dyspnoea—Glimepiride—type 2 diabetes mellitus	0.00388	0.00458	CcSEcCtD
Methohexital—Nausea—Nateglinide—type 2 diabetes mellitus	0.00387	0.00457	CcSEcCtD
Methohexital—Shock—Bromocriptine—type 2 diabetes mellitus	0.00386	0.00456	CcSEcCtD
Methohexital—Liver function test abnormal—Ramipril—type 2 diabetes mellitus	0.00386	0.00456	CcSEcCtD
Methohexital—Tachycardia—Bromocriptine—type 2 diabetes mellitus	0.00383	0.00453	CcSEcCtD
Methohexital—Gastrointestinal pain—Glipizide—type 2 diabetes mellitus	0.00381	0.00451	CcSEcCtD
Methohexital—Convulsion—Glyburide—type 2 diabetes mellitus	0.00381	0.0045	CcSEcCtD
Methohexital—Rhinitis—Metformin—type 2 diabetes mellitus	0.0038	0.0045	CcSEcCtD
Methohexital—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.00377	0.00445	CcSEcCtD
Methohexital—Urticaria—Glipizide—type 2 diabetes mellitus	0.0037	0.00438	CcSEcCtD
Methohexital—Abdominal pain—Glipizide—type 2 diabetes mellitus	0.00369	0.00436	CcSEcCtD
Methohexital—Hypotension—Bromocriptine—type 2 diabetes mellitus	0.00367	0.00434	CcSEcCtD
Methohexital—Agitation—Gliclazide—type 2 diabetes mellitus	0.00363	0.00429	CcSEcCtD
Methohexital—Rhinitis—Irbesartan—type 2 diabetes mellitus	0.00359	0.00424	CcSEcCtD
Methohexital—Vomiting—Repaglinide—type 2 diabetes mellitus	0.00358	0.00423	CcSEcCtD
Methohexital—Gastrointestinal pain—Glimepiride—type 2 diabetes mellitus	0.00356	0.00421	CcSEcCtD
Methohexital—Bronchospasm—Ramipril—type 2 diabetes mellitus	0.00355	0.0042	CcSEcCtD
Methohexital—Urticaria—Pioglitazone—type 2 diabetes mellitus	0.00355	0.00419	CcSEcCtD
Methohexital—Gastrointestinal pain—Sitagliptin—type 2 diabetes mellitus	0.00355	0.00419	CcSEcCtD
Methohexital—Headache—Repaglinide—type 2 diabetes mellitus	0.00353	0.00417	CcSEcCtD
Methohexital—Shock—Glyburide—type 2 diabetes mellitus	0.00353	0.00417	CcSEcCtD
Methohexital—Dyspnoea—Bromocriptine—type 2 diabetes mellitus	0.0035	0.00414	CcSEcCtD
Methohexital—Urticaria—Glimepiride—type 2 diabetes mellitus	0.00346	0.00409	CcSEcCtD
Methohexital—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.00345	0.00407	CcSEcCtD
Methohexital—Abdominal pain—Glimepiride—type 2 diabetes mellitus	0.00344	0.00407	CcSEcCtD
Methohexital—Abdominal pain—Sitagliptin—type 2 diabetes mellitus	0.00343	0.00405	CcSEcCtD
Methohexital—Convulsion—Gliclazide—type 2 diabetes mellitus	0.00342	0.00404	CcSEcCtD
Methohexital—Rhinitis—Losartan—type 2 diabetes mellitus	0.00338	0.00399	CcSEcCtD
Methohexital—Hypotension—Glyburide—type 2 diabetes mellitus	0.00335	0.00396	CcSEcCtD
Methohexital—Anxiety—Gliclazide—type 2 diabetes mellitus	0.00335	0.00396	CcSEcCtD
Methohexital—Nausea—Repaglinide—type 2 diabetes mellitus	0.00335	0.00396	CcSEcCtD
Methohexital—Headache—Rosiglitazone—type 2 diabetes mellitus	0.00334	0.00394	CcSEcCtD
Methohexital—Erythema—Metformin—type 2 diabetes mellitus	0.0033	0.0039	CcSEcCtD
Methohexital—Pruritus—Glipizide—type 2 diabetes mellitus	0.0033	0.0039	CcSEcCtD
Methohexital—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	0.00321	0.00379	CcSEcCtD
Methohexital—Dyspnoea—Glyburide—type 2 diabetes mellitus	0.0032	0.00378	CcSEcCtD
Methohexital—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.00316	0.00374	CcSEcCtD
Methohexital—Tachycardia—Gliclazide—type 2 diabetes mellitus	0.00315	0.00372	CcSEcCtD
Methohexital—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.00312	0.00369	CcSEcCtD
Methohexital—Erythema—Irbesartan—type 2 diabetes mellitus	0.00312	0.00368	CcSEcCtD
Methohexital—Convulsion—Orlistat—type 2 diabetes mellitus	0.00311	0.00367	CcSEcCtD
Methohexital—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.0031	0.00367	CcSEcCtD
Methohexital—Pruritus—Glimepiride—type 2 diabetes mellitus	0.00308	0.00364	CcSEcCtD
Methohexital—Anxiety—Valsartan—type 2 diabetes mellitus	0.00308	0.00364	CcSEcCtD
Methohexital—Anxiety—Orlistat—type 2 diabetes mellitus	0.00304	0.00359	CcSEcCtD
Methohexital—GABRA1—SIDS Susceptibility Pathways—PHOX2A—type 2 diabetes mellitus	0.00304	0.0209	CbGpPWpGaD
Methohexital—Hypotension—Gliclazide—type 2 diabetes mellitus	0.00301	0.00356	CcSEcCtD
Methohexital—Vomiting—Glipizide—type 2 diabetes mellitus	0.00296	0.0035	CcSEcCtD
Methohexital—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.00296	0.0035	CcSEcCtD
Methohexital—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.00293	0.00347	CcSEcCtD
Methohexital—Erythema—Losartan—type 2 diabetes mellitus	0.00293	0.00347	CcSEcCtD
Methohexital—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.00293	0.00346	CcSEcCtD
Methohexital—Headache—Glipizide—type 2 diabetes mellitus	0.00292	0.00345	CcSEcCtD
Methohexital—Shock—Valsartan—type 2 diabetes mellitus	0.00291	0.00344	CcSEcCtD
Methohexital—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.00287	0.0034	CcSEcCtD
Methohexital—Agitation—Irbesartan—type 2 diabetes mellitus	0.00287	0.00339	CcSEcCtD
Methohexital—Urticaria—Glyburide—type 2 diabetes mellitus	0.00285	0.00337	CcSEcCtD
Methohexital—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.00284	0.00335	CcSEcCtD
Methohexital—Headache—Pioglitazone—type 2 diabetes mellitus	0.0028	0.00331	CcSEcCtD
Methohexital—Nausea—Glipizide—type 2 diabetes mellitus	0.00277	0.00327	CcSEcCtD
Methohexital—Vomiting—Glimepiride—type 2 diabetes mellitus	0.00277	0.00327	CcSEcCtD
Methohexital—Hypotension—Valsartan—type 2 diabetes mellitus	0.00277	0.00327	CcSEcCtD
Methohexital—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.00276	0.00326	CcSEcCtD
Methohexital—Headache—Glimepiride—type 2 diabetes mellitus	0.00273	0.00322	CcSEcCtD
Methohexital—Headache—Sitagliptin—type 2 diabetes mellitus	0.00272	0.00321	CcSEcCtD
Methohexital—Agitation—Losartan—type 2 diabetes mellitus	0.0027	0.00319	CcSEcCtD
Methohexital—Shock—Metformin—type 2 diabetes mellitus	0.00265	0.00313	CcSEcCtD
Methohexital—Anxiety—Irbesartan—type 2 diabetes mellitus	0.00265	0.00313	CcSEcCtD
Methohexital—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.00264	0.00312	CcSEcCtD
Methohexital—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.00264	0.00311	CcSEcCtD
Methohexital—Nausea—Glimepiride—type 2 diabetes mellitus	0.00258	0.00305	CcSEcCtD
Methohexital—Nausea—Sitagliptin—type 2 diabetes mellitus	0.00258	0.00304	CcSEcCtD
Methohexital—Urticaria—Gliclazide—type 2 diabetes mellitus	0.00256	0.00303	CcSEcCtD
Methohexital—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.00255	0.00301	CcSEcCtD
Methohexital—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.00254	0.00301	CcSEcCtD
Methohexital—Pruritus—Glyburide—type 2 diabetes mellitus	0.00254	0.003	CcSEcCtD
Methohexital—Hypotension—Metformin—type 2 diabetes mellitus	0.00252	0.00298	CcSEcCtD
Methohexital—Erythema—Ramipril—type 2 diabetes mellitus	0.00252	0.00297	CcSEcCtD
Methohexital—Shock—Irbesartan—type 2 diabetes mellitus	0.0025	0.00296	CcSEcCtD
Methohexital—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.0025	0.00295	CcSEcCtD
Methohexital—Anxiety—Losartan—type 2 diabetes mellitus	0.00249	0.00294	CcSEcCtD
Methohexital—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.00248	0.00293	CcSEcCtD
Methohexital—GABRB3—Orphan transporters—SLC5A4—type 2 diabetes mellitus	0.00247	0.017	CbGpPWpGaD
Methohexital—Headache—Bromocriptine—type 2 diabetes mellitus	0.00246	0.00291	CcSEcCtD
Methohexital—GABRG2—Orphan transporters—SLC5A4—type 2 diabetes mellitus	0.00243	0.0167	CbGpPWpGaD
Methohexital—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.00242	0.00286	CcSEcCtD
Methohexital—Dyspnoea—Metformin—type 2 diabetes mellitus	0.0024	0.00284	CcSEcCtD
Methohexital—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.00239	0.00283	CcSEcCtD
Methohexital—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.00239	0.00283	CcSEcCtD
Methohexital—Hypotension—Irbesartan—type 2 diabetes mellitus	0.00238	0.00281	CcSEcCtD
Methohexital—Shock—Losartan—type 2 diabetes mellitus	0.00236	0.00278	CcSEcCtD
Methohexital—Urticaria—Valsartan—type 2 diabetes mellitus	0.00235	0.00278	CcSEcCtD
Methohexital—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.00234	0.00277	CcSEcCtD
Methohexital—Tachycardia—Losartan—type 2 diabetes mellitus	0.00234	0.00276	CcSEcCtD
Methohexital—Nausea—Bromocriptine—type 2 diabetes mellitus	0.00233	0.00276	CcSEcCtD
Methohexital—Urticaria—Orlistat—type 2 diabetes mellitus	0.00232	0.00275	CcSEcCtD
Methohexital—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.00231	0.00273	CcSEcCtD
Methohexital—Agitation—Ramipril—type 2 diabetes mellitus	0.00231	0.00273	CcSEcCtD
Methohexital—Vomiting—Glyburide—type 2 diabetes mellitus	0.00228	0.0027	CcSEcCtD
Methohexital—Pruritus—Gliclazide—type 2 diabetes mellitus	0.00228	0.00269	CcSEcCtD
Methohexital—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.00227	0.00268	CcSEcCtD
Methohexital—Headache—Glyburide—type 2 diabetes mellitus	0.00225	0.00266	CcSEcCtD
Methohexital—Hypotension—Losartan—type 2 diabetes mellitus	0.00224	0.00264	CcSEcCtD
Methohexital—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.0022	0.00261	CcSEcCtD
Methohexital—Convulsion—Ramipril—type 2 diabetes mellitus	0.00218	0.00258	CcSEcCtD
Methohexital—Urticaria—Metformin—type 2 diabetes mellitus	0.00214	0.00253	CcSEcCtD
Methohexital—Dyspnoea—Losartan—type 2 diabetes mellitus	0.00213	0.00252	CcSEcCtD
Methohexital—Anxiety—Ramipril—type 2 diabetes mellitus	0.00213	0.00252	CcSEcCtD
Methohexital—Nausea—Glyburide—type 2 diabetes mellitus	0.00213	0.00252	CcSEcCtD
Methohexital—Abdominal pain—Metformin—type 2 diabetes mellitus	0.00213	0.00252	CcSEcCtD
Methohexital—GABRA1—Orphan transporters—SLC5A4—type 2 diabetes mellitus	0.00212	0.0146	CbGpPWpGaD
Methohexital—Pruritus—Valsartan—type 2 diabetes mellitus	0.00209	0.00248	CcSEcCtD
Methohexital—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.00208	0.00246	CcSEcCtD
Methohexital—Pruritus—Orlistat—type 2 diabetes mellitus	0.00207	0.00245	CcSEcCtD
Methohexital—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.00205	0.00243	CcSEcCtD
Methohexital—Vomiting—Gliclazide—type 2 diabetes mellitus	0.00205	0.00242	CcSEcCtD
Methohexital—Urticaria—Irbesartan—type 2 diabetes mellitus	0.00202	0.00239	CcSEcCtD
Methohexital—Shock—Ramipril—type 2 diabetes mellitus	0.00202	0.00239	CcSEcCtD
Methohexital—Headache—Gliclazide—type 2 diabetes mellitus	0.00202	0.00239	CcSEcCtD
Methohexital—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.00201	0.00238	CcSEcCtD
Methohexital—Tachycardia—Ramipril—type 2 diabetes mellitus	0.002	0.00237	CcSEcCtD
Methohexital—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.00196	0.00231	CcSEcCtD
Methohexital—GABRA1—SIDS Susceptibility Pathways—NEUROD1—type 2 diabetes mellitus	0.00196	0.0135	CbGpPWpGaD
Methohexital—Secobarbital—CYP1A2—type 2 diabetes mellitus	0.00195	0.226	CrCbGaD
Methohexital—Hypotension—Ramipril—type 2 diabetes mellitus	0.00192	0.00227	CcSEcCtD
Methohexital—Nausea—Gliclazide—type 2 diabetes mellitus	0.00191	0.00226	CcSEcCtD
Methohexital—Pruritus—Metformin—type 2 diabetes mellitus	0.00191	0.00225	CcSEcCtD
Methohexital—Urticaria—Losartan—type 2 diabetes mellitus	0.0019	0.00225	CcSEcCtD
Methohexital—Abdominal pain—Losartan—type 2 diabetes mellitus	0.00189	0.00224	CcSEcCtD
Methohexital—Vomiting—Valsartan—type 2 diabetes mellitus	0.00188	0.00222	CcSEcCtD
Methohexital—GABRB3—Orphan transporters—SLC5A2—type 2 diabetes mellitus	0.00187	0.0129	CbGpPWpGaD
Methohexital—GABRB3—Orphan transporters—COX2—type 2 diabetes mellitus	0.00187	0.0129	CbGpPWpGaD
Methohexital—Vomiting—Orlistat—type 2 diabetes mellitus	0.00186	0.0022	CcSEcCtD
Methohexital—Headache—Valsartan—type 2 diabetes mellitus	0.00185	0.00219	CcSEcCtD
Methohexital—GABRB3—Orphan transporters—NCOA6—type 2 diabetes mellitus	0.00184	0.0127	CbGpPWpGaD
Methohexital—GABRG2—Orphan transporters—SLC5A2—type 2 diabetes mellitus	0.00184	0.0127	CbGpPWpGaD
Methohexital—GABRG2—Orphan transporters—COX2—type 2 diabetes mellitus	0.00184	0.0127	CbGpPWpGaD
Methohexital—Headache—Orlistat—type 2 diabetes mellitus	0.00183	0.00217	CcSEcCtD
Methohexital—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.00183	0.00216	CcSEcCtD
Methohexital—GABRG2—Orphan transporters—NCOA6—type 2 diabetes mellitus	0.00181	0.0125	CbGpPWpGaD
Methohexital—Pruritus—Irbesartan—type 2 diabetes mellitus	0.0018	0.00213	CcSEcCtD
Methohexital—Nausea—Valsartan—type 2 diabetes mellitus	0.00176	0.00208	CcSEcCtD
Methohexital—Nausea—Orlistat—type 2 diabetes mellitus	0.00174	0.00205	CcSEcCtD
Methohexital—Vomiting—Metformin—type 2 diabetes mellitus	0.00171	0.00203	CcSEcCtD
Methohexital—Pruritus—Losartan—type 2 diabetes mellitus	0.00169	0.002	CcSEcCtD
Methohexital—Headache—Metformin—type 2 diabetes mellitus	0.00169	0.002	CcSEcCtD
Methohexital—GABRB3—Neuronal System—KCNK16—type 2 diabetes mellitus	0.00168	0.0116	CbGpPWpGaD
Methohexital—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.00168	0.00198	CcSEcCtD
Methohexital—GABRB3—Ion channel transport—TRPC1—type 2 diabetes mellitus	0.00168	0.0115	CbGpPWpGaD
Methohexital—GABRG2—Neuronal System—KCNK16—type 2 diabetes mellitus	0.00165	0.0114	CbGpPWpGaD
Methohexital—GABRG2—Ion channel transport—TRPC1—type 2 diabetes mellitus	0.00165	0.0113	CbGpPWpGaD
Methohexital—Urticaria—Ramipril—type 2 diabetes mellitus	0.00163	0.00193	CcSEcCtD
Methohexital—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.00162	0.00192	CcSEcCtD
Methohexital—Vomiting—Irbesartan—type 2 diabetes mellitus	0.00162	0.00191	CcSEcCtD
Methohexital—GABRA1—Orphan transporters—COX2—type 2 diabetes mellitus	0.00161	0.0111	CbGpPWpGaD
Methohexital—GABRA1—Orphan transporters—SLC5A2—type 2 diabetes mellitus	0.00161	0.0111	CbGpPWpGaD
Methohexital—Nausea—Metformin—type 2 diabetes mellitus	0.0016	0.00189	CcSEcCtD
Methohexital—GABRA1—SIDS Susceptibility Pathways—KCNQ1—type 2 diabetes mellitus	0.00159	0.011	CbGpPWpGaD
Methohexital—Headache—Irbesartan—type 2 diabetes mellitus	0.00159	0.00188	CcSEcCtD
Methohexital—GABRA1—Orphan transporters—NCOA6—type 2 diabetes mellitus	0.00158	0.0109	CbGpPWpGaD
Methohexital—GABRB3—Ion channel transport—PLN—type 2 diabetes mellitus	0.00153	0.0106	CbGpPWpGaD
Methohexital—Vomiting—Losartan—type 2 diabetes mellitus	0.00152	0.0018	CcSEcCtD
Methohexital—Nausea—Irbesartan—type 2 diabetes mellitus	0.00151	0.00179	CcSEcCtD
Methohexital—GABRG2—Ion channel transport—PLN—type 2 diabetes mellitus	0.0015	0.0104	CbGpPWpGaD
Methohexital—Headache—Losartan—type 2 diabetes mellitus	0.0015	0.00177	CcSEcCtD
Methohexital—GABRA1—SIDS Susceptibility Pathways—ECE1—type 2 diabetes mellitus	0.00148	0.0102	CbGpPWpGaD
Methohexital—GABRA1—SIDS Susceptibility Pathways—G6PC—type 2 diabetes mellitus	0.00148	0.0102	CbGpPWpGaD
Methohexital—Pruritus—Ramipril—type 2 diabetes mellitus	0.00145	0.00172	CcSEcCtD
Methohexital—GABRA1—Neuronal System—KCNK16—type 2 diabetes mellitus	0.00144	0.00995	CbGpPWpGaD
Methohexital—GABRA1—Ion channel transport—TRPC1—type 2 diabetes mellitus	0.00144	0.00991	CbGpPWpGaD
Methohexital—Nausea—Losartan—type 2 diabetes mellitus	0.00142	0.00168	CcSEcCtD
Methohexital—GABRB3—GABA receptor activation—GNB3—type 2 diabetes mellitus	0.00141	0.00968	CbGpPWpGaD
Methohexital—GABRG2—GABA receptor activation—GNB3—type 2 diabetes mellitus	0.00138	0.00951	CbGpPWpGaD
Methohexital—GABRA1—Ion channel transport—PLN—type 2 diabetes mellitus	0.00132	0.00906	CbGpPWpGaD
Methohexital—Vomiting—Ramipril—type 2 diabetes mellitus	0.00131	0.00154	CcSEcCtD
Methohexital—Headache—Ramipril—type 2 diabetes mellitus	0.00129	0.00152	CcSEcCtD
Methohexital—GABRB3—GABA receptor activation—ADCY5—type 2 diabetes mellitus	0.00125	0.00863	CbGpPWpGaD
Methohexital—GABRG2—GABA receptor activation—ADCY5—type 2 diabetes mellitus	0.00123	0.00847	CbGpPWpGaD
Methohexital—Nausea—Ramipril—type 2 diabetes mellitus	0.00122	0.00144	CcSEcCtD
Methohexital—Pentobarbital—CYP3A4—type 2 diabetes mellitus	0.00122	0.141	CrCbGaD
Methohexital—GABRA1—GABA receptor activation—GNB3—type 2 diabetes mellitus	0.00121	0.00831	CbGpPWpGaD
Methohexital—GABRB3—Ion channel transport—ATP2A3—type 2 diabetes mellitus	0.00119	0.00823	CbGpPWpGaD
Methohexital—GABRB3—Orphan transporters—CETP—type 2 diabetes mellitus	0.00118	0.00813	CbGpPWpGaD
Methohexital—GABRG2—Ion channel transport—ATP2A3—type 2 diabetes mellitus	0.00117	0.00808	CbGpPWpGaD
Methohexital—GABRB3—Neuronal System—KCNQ1—type 2 diabetes mellitus	0.00117	0.00804	CbGpPWpGaD
Methohexital—GABRG2—Orphan transporters—CETP—type 2 diabetes mellitus	0.00116	0.00798	CbGpPWpGaD
Methohexital—GABRG2—Neuronal System—KCNQ1—type 2 diabetes mellitus	0.00115	0.00789	CbGpPWpGaD
Methohexital—GABRB3—BDNF signaling pathway—PRKAA1—type 2 diabetes mellitus	0.00109	0.00754	CbGpPWpGaD
Methohexital—GABRA1—GABA receptor activation—ADCY5—type 2 diabetes mellitus	0.00108	0.00741	CbGpPWpGaD
Methohexital—GABRB3—Orphan transporters—PLAT—type 2 diabetes mellitus	0.00104	0.00716	CbGpPWpGaD
Methohexital—GABRA1—Ion channel transport—ATP2A3—type 2 diabetes mellitus	0.00102	0.00706	CbGpPWpGaD
Methohexital—GABRG2—Orphan transporters—PLAT—type 2 diabetes mellitus	0.00102	0.00703	CbGpPWpGaD
Methohexital—GABRA1—Orphan transporters—CETP—type 2 diabetes mellitus	0.00101	0.00698	CbGpPWpGaD
Methohexital—GABRB3—Transmission across Chemical Synapses—GAD2—type 2 diabetes mellitus	0.00101	0.00695	CbGpPWpGaD
Methohexital—GABRA1—Neuronal System—KCNQ1—type 2 diabetes mellitus	0.001	0.0069	CbGpPWpGaD
Methohexital—GABRG2—Transmission across Chemical Synapses—GAD2—type 2 diabetes mellitus	0.00099	0.00682	CbGpPWpGaD
Methohexital—GABRB3—Transmembrane transport of small molecules—SLC26A9—type 2 diabetes mellitus	0.000905	0.00624	CbGpPWpGaD
Methohexital—GABRA1—Orphan transporters—PLAT—type 2 diabetes mellitus	0.000892	0.00615	CbGpPWpGaD
Methohexital—GABRG2—Transmembrane transport of small molecules—SLC26A9—type 2 diabetes mellitus	0.000889	0.00612	CbGpPWpGaD
Methohexital—GABRB3—Neuronal System—ABCC8—type 2 diabetes mellitus	0.000884	0.00609	CbGpPWpGaD
Methohexital—GABRG2—Neuronal System—ABCC8—type 2 diabetes mellitus	0.000868	0.00598	CbGpPWpGaD
Methohexital—GABRA1—Transmission across Chemical Synapses—GAD2—type 2 diabetes mellitus	0.000866	0.00597	CbGpPWpGaD
Methohexital—GABRB3—Ion channel transport—ATP2A2—type 2 diabetes mellitus	0.000858	0.00591	CbGpPWpGaD
Methohexital—GABRG2—Ion channel transport—ATP2A2—type 2 diabetes mellitus	0.000842	0.0058	CbGpPWpGaD
Methohexital—GABRB3—Ion channel transport—TRPC6—type 2 diabetes mellitus	0.000832	0.00573	CbGpPWpGaD
Methohexital—GABRG2—Ion channel transport—TRPC6—type 2 diabetes mellitus	0.000817	0.00563	CbGpPWpGaD
Methohexital—GABRB3—Orphan transporters—APOB—type 2 diabetes mellitus	0.000781	0.00538	CbGpPWpGaD
Methohexital—GABRA1—SIDS Susceptibility Pathways—CPT1A—type 2 diabetes mellitus	0.000779	0.00536	CbGpPWpGaD
Methohexital—GABRA1—Transmembrane transport of small molecules—SLC26A9—type 2 diabetes mellitus	0.000777	0.00535	CbGpPWpGaD
Methohexital—GABRB3—Neuronal System—GAD2—type 2 diabetes mellitus	0.000773	0.00532	CbGpPWpGaD
Methohexital—GABRG2—Orphan transporters—APOB—type 2 diabetes mellitus	0.000767	0.00529	CbGpPWpGaD
Methohexital—GABRG2—Neuronal System—GAD2—type 2 diabetes mellitus	0.000759	0.00523	CbGpPWpGaD
Methohexital—GABRA1—Neuronal System—ABCC8—type 2 diabetes mellitus	0.000759	0.00523	CbGpPWpGaD
Methohexital—GABRA1—SIDS Susceptibility Pathways—GCK—type 2 diabetes mellitus	0.000759	0.00523	CbGpPWpGaD
Methohexital—GABRA1—Ion channel transport—ATP2A2—type 2 diabetes mellitus	0.000736	0.00507	CbGpPWpGaD
Methohexital—GABRA1—Ion channel transport—TRPC6—type 2 diabetes mellitus	0.000714	0.00492	CbGpPWpGaD
Methohexital—GABRB3—Neuronal System—KCNJ11—type 2 diabetes mellitus	0.000699	0.00482	CbGpPWpGaD
Methohexital—GABRG2—Neuronal System—KCNJ11—type 2 diabetes mellitus	0.000686	0.00473	CbGpPWpGaD
Methohexital—GABRA1—SIDS Susceptibility Pathways—SNAP25—type 2 diabetes mellitus	0.000681	0.00469	CbGpPWpGaD
Methohexital—GABRA1—Orphan transporters—APOB—type 2 diabetes mellitus	0.000671	0.00462	CbGpPWpGaD
Methohexital—GABRA1—Neuronal System—GAD2—type 2 diabetes mellitus	0.000663	0.00457	CbGpPWpGaD
Methohexital—GABRB3—Orphan transporters—PPARA—type 2 diabetes mellitus	0.000659	0.00454	CbGpPWpGaD
Methohexital—GABRB3—Transmission across Chemical Synapses—SNAP25—type 2 diabetes mellitus	0.00065	0.00448	CbGpPWpGaD
Methohexital—GABRG2—Orphan transporters—PPARA—type 2 diabetes mellitus	0.000647	0.00446	CbGpPWpGaD
Methohexital—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GNB3—type 2 diabetes mellitus	0.000646	0.00445	CbGpPWpGaD
Methohexital—GABRG2—Transmission across Chemical Synapses—SNAP25—type 2 diabetes mellitus	0.000638	0.0044	CbGpPWpGaD
Methohexital—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GNB3—type 2 diabetes mellitus	0.000634	0.00437	CbGpPWpGaD
Methohexital—GABRB3—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	0.000604	0.00416	CbGpPWpGaD
Methohexital—GABRA1—Neuronal System—KCNJ11—type 2 diabetes mellitus	0.0006	0.00413	CbGpPWpGaD
Methohexital—GABRG2—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	0.000593	0.00409	CbGpPWpGaD
Methohexital—GABRB3—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	0.000583	0.00402	CbGpPWpGaD
Methohexital—GABRB3—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	0.000583	0.00402	CbGpPWpGaD
Methohexital—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—type 2 diabetes mellitus	0.000576	0.00397	CbGpPWpGaD
Methohexital—GABRG2—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	0.000573	0.00395	CbGpPWpGaD
Methohexital—GABRG2—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	0.000573	0.00395	CbGpPWpGaD
Methohexital—GABRA1—Orphan transporters—PPARA—type 2 diabetes mellitus	0.000566	0.0039	CbGpPWpGaD
Methohexital—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—type 2 diabetes mellitus	0.000566	0.0039	CbGpPWpGaD
Methohexital—GABRA1—Transmission across Chemical Synapses—SNAP25—type 2 diabetes mellitus	0.000558	0.00384	CbGpPWpGaD
Methohexital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GNB3—type 2 diabetes mellitus	0.000555	0.00382	CbGpPWpGaD
Methohexital—GABRA1—SIDS Susceptibility Pathways—GJA1—type 2 diabetes mellitus	0.000544	0.00375	CbGpPWpGaD
Methohexital—GABRA1—SIDS Susceptibility Pathways—AR—type 2 diabetes mellitus	0.00054	0.00372	CbGpPWpGaD
Methohexital—GABRB3—BDNF signaling pathway—PPP2CA—type 2 diabetes mellitus	0.00054	0.00372	CbGpPWpGaD
Methohexital—GABRB3—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	0.000533	0.00367	CbGpPWpGaD
Methohexital—GABRG2—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	0.000524	0.00361	CbGpPWpGaD
Methohexital—GABRA1—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	0.000518	0.00357	CbGpPWpGaD
Methohexital—GABRA1—SIDS Susceptibility Pathways—PPARGC1A—type 2 diabetes mellitus	0.000509	0.0035	CbGpPWpGaD
Methohexital—GABRA1—SIDS Susceptibility Pathways—GNB3—type 2 diabetes mellitus	0.000509	0.0035	CbGpPWpGaD
Methohexital—GABRA1—SIDS Susceptibility Pathways—AVP—type 2 diabetes mellitus	0.000502	0.00346	CbGpPWpGaD
Methohexital—GABRA1—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	0.000501	0.00345	CbGpPWpGaD
Methohexital—GABRA1—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	0.000501	0.00345	CbGpPWpGaD
Methohexital—GABRB3—Neuronal System—SNAP25—type 2 diabetes mellitus	0.000498	0.00343	CbGpPWpGaD
Methohexital—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CALM1—type 2 diabetes mellitus	0.000495	0.00341	CbGpPWpGaD
Methohexital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—type 2 diabetes mellitus	0.000494	0.00341	CbGpPWpGaD
Methohexital—GABRB3—BDNF signaling pathway—IRS2—type 2 diabetes mellitus	0.000493	0.00339	CbGpPWpGaD
Methohexital—GABRG2—Neuronal System—SNAP25—type 2 diabetes mellitus	0.000489	0.00337	CbGpPWpGaD
Methohexital—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CALM1—type 2 diabetes mellitus	0.000486	0.00335	CbGpPWpGaD
Methohexital—GABRB3—Transmission across Chemical Synapses—GNB3—type 2 diabetes mellitus	0.000486	0.00335	CbGpPWpGaD
Methohexital—GABRG2—Transmission across Chemical Synapses—GNB3—type 2 diabetes mellitus	0.000477	0.00329	CbGpPWpGaD
Methohexital—GABRB3—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	0.000475	0.00328	CbGpPWpGaD
Methohexital—GABRB3—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	0.000475	0.00328	CbGpPWpGaD
Methohexital—GABRG2—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	0.000467	0.00322	CbGpPWpGaD
Methohexital—GABRG2—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	0.000467	0.00322	CbGpPWpGaD
Methohexital—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCB—type 2 diabetes mellitus	0.000465	0.0032	CbGpPWpGaD
Methohexital—GABRA1—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	0.000458	0.00315	CbGpPWpGaD
Methohexital—GABRB3—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	0.000458	0.00315	CbGpPWpGaD
Methohexital—GABRB3—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	0.000458	0.00315	CbGpPWpGaD
Methohexital—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCB—type 2 diabetes mellitus	0.000457	0.00315	CbGpPWpGaD
Methohexital—GABRB3—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	0.00045	0.0031	CbGpPWpGaD
Methohexital—GABRG2—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	0.000449	0.0031	CbGpPWpGaD
Methohexital—GABRG2—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	0.000449	0.0031	CbGpPWpGaD
Methohexital—GABRG2—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	0.000441	0.00304	CbGpPWpGaD
Methohexital—GABRA1—SIDS Susceptibility Pathways—NR3C1—type 2 diabetes mellitus	0.000436	0.00301	CbGpPWpGaD
Methohexital—GABRB3—Transmission across Chemical Synapses—ADCY5—type 2 diabetes mellitus	0.000433	0.00298	CbGpPWpGaD
Methohexital—GABRB3—BDNF signaling pathway—IRS1—type 2 diabetes mellitus	0.00043	0.00296	CbGpPWpGaD
Methohexital—GABRA1—Neuronal System—SNAP25—type 2 diabetes mellitus	0.000427	0.00295	CbGpPWpGaD
Methohexital—GABRG2—Transmission across Chemical Synapses—ADCY5—type 2 diabetes mellitus	0.000425	0.00293	CbGpPWpGaD
Methohexital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CALM1—type 2 diabetes mellitus	0.000425	0.00293	CbGpPWpGaD
Methohexital—GABRA1—Transmission across Chemical Synapses—GNB3—type 2 diabetes mellitus	0.000417	0.00287	CbGpPWpGaD
Methohexital—GABRB3—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	0.000416	0.00286	CbGpPWpGaD
Methohexital—GABRG2—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	0.000408	0.00281	CbGpPWpGaD
Methohexital—GABRA1—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	0.000408	0.00281	CbGpPWpGaD
Methohexital—GABRA1—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	0.000408	0.00281	CbGpPWpGaD
Methohexital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCB—type 2 diabetes mellitus	0.000399	0.00275	CbGpPWpGaD
Methohexital—GABRA1—SIDS Susceptibility Pathways—HIF1A—type 2 diabetes mellitus	0.000398	0.00274	CbGpPWpGaD
Methohexital—GABRA1—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	0.000393	0.00271	CbGpPWpGaD
Methohexital—GABRA1—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	0.000393	0.00271	CbGpPWpGaD
Methohexital—GABRB3—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	0.000389	0.00268	CbGpPWpGaD
Methohexital—GABRA1—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	0.000386	0.00266	CbGpPWpGaD
Methohexital—GABRG2—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	0.000382	0.00263	CbGpPWpGaD
Methohexital—GABRB3—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	0.000376	0.00259	CbGpPWpGaD
Methohexital—GABRB3—Neuronal System—GNB3—type 2 diabetes mellitus	0.000372	0.00256	CbGpPWpGaD
Methohexital—GABRB3—Transmission across Chemical Synapses—CALM1—type 2 diabetes mellitus	0.000372	0.00256	CbGpPWpGaD
Methohexital—GABRA1—Transmission across Chemical Synapses—ADCY5—type 2 diabetes mellitus	0.000372	0.00256	CbGpPWpGaD
Methohexital—GABRG2—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	0.000369	0.00254	CbGpPWpGaD
Methohexital—GABRG2—Neuronal System—GNB3—type 2 diabetes mellitus	0.000365	0.00252	CbGpPWpGaD
Methohexital—GABRG2—Transmission across Chemical Synapses—CALM1—type 2 diabetes mellitus	0.000365	0.00252	CbGpPWpGaD
Methohexital—GABRB3—BDNF signaling pathway—PIK3R1—type 2 diabetes mellitus	0.000361	0.00249	CbGpPWpGaD
Methohexital—GABRB3—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	0.00036	0.00248	CbGpPWpGaD
Methohexital—GABRA1—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	0.000357	0.00246	CbGpPWpGaD
Methohexital—GABRG2—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	0.000354	0.00244	CbGpPWpGaD
Methohexital—GABRB3—Transmission across Chemical Synapses—PRKCB—type 2 diabetes mellitus	0.00035	0.00241	CbGpPWpGaD
Methohexital—GABRG2—Transmission across Chemical Synapses—PRKCB—type 2 diabetes mellitus	0.000343	0.00237	CbGpPWpGaD
Methohexital—GABRB3—BDNF signaling pathway—RELA—type 2 diabetes mellitus	0.00034	0.00234	CbGpPWpGaD
Methohexital—GABRA1—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	0.000334	0.0023	CbGpPWpGaD
Methohexital—GABRB3—Neuronal System—ADCY5—type 2 diabetes mellitus	0.000332	0.00229	CbGpPWpGaD
Methohexital—GABRG2—Neuronal System—ADCY5—type 2 diabetes mellitus	0.000326	0.00224	CbGpPWpGaD
Methohexital—GABRA1—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	0.000323	0.00222	CbGpPWpGaD
Methohexital—GABRA1—Neuronal System—GNB3—type 2 diabetes mellitus	0.000319	0.0022	CbGpPWpGaD
Methohexital—GABRA1—Transmission across Chemical Synapses—CALM1—type 2 diabetes mellitus	0.000319	0.0022	CbGpPWpGaD
Methohexital—GABRB3—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	0.000313	0.00215	CbGpPWpGaD
Methohexital—GABRA1—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	0.000309	0.00213	CbGpPWpGaD
Methohexital—GABRG2—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	0.000307	0.00212	CbGpPWpGaD
Methohexital—GABRB3—BDNF signaling pathway—CASP3—type 2 diabetes mellitus	0.000307	0.00211	CbGpPWpGaD
Methohexital—GABRA1—Transmission across Chemical Synapses—PRKCB—type 2 diabetes mellitus	0.0003	0.00207	CbGpPWpGaD
Methohexital—GABRB3—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	0.000299	0.00206	CbGpPWpGaD
Methohexital—GABRB3—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	0.000299	0.00206	CbGpPWpGaD
Methohexital—GABRG2—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	0.000293	0.00202	CbGpPWpGaD
Methohexital—GABRG2—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	0.000293	0.00202	CbGpPWpGaD
Methohexital—GABRB3—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	0.000291	0.00201	CbGpPWpGaD
Methohexital—GABRB3—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	0.00029	0.002	CbGpPWpGaD
Methohexital—GABRB3—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	0.000288	0.00198	CbGpPWpGaD
Methohexital—GABRB3—BDNF signaling pathway—NFKB1—type 2 diabetes mellitus	0.000287	0.00198	CbGpPWpGaD
Methohexital—GABRG2—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	0.000286	0.00197	CbGpPWpGaD
Methohexital—GABRB3—Neuronal System—CALM1—type 2 diabetes mellitus	0.000285	0.00196	CbGpPWpGaD
Methohexital—GABRA1—Neuronal System—ADCY5—type 2 diabetes mellitus	0.000285	0.00196	CbGpPWpGaD
Methohexital—GABRG2—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	0.000284	0.00196	CbGpPWpGaD
Methohexital—GABRG2—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	0.000283	0.00195	CbGpPWpGaD
Methohexital—GABRG2—Neuronal System—CALM1—type 2 diabetes mellitus	0.00028	0.00193	CbGpPWpGaD
Methohexital—GABRA1—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	0.000268	0.00185	CbGpPWpGaD
Methohexital—GABRB3—Neuronal System—PRKCB—type 2 diabetes mellitus	0.000268	0.00185	CbGpPWpGaD
Methohexital—GABRB3—BDNF signaling pathway—SRC—type 2 diabetes mellitus	0.000267	0.00184	CbGpPWpGaD
Methohexital—GABRG2—Neuronal System—PRKCB—type 2 diabetes mellitus	0.000263	0.00181	CbGpPWpGaD
Methohexital—GABRA1—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	0.000256	0.00177	CbGpPWpGaD
Methohexital—GABRA1—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	0.000256	0.00177	CbGpPWpGaD
Methohexital—GABRB3—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	0.000254	0.00175	CbGpPWpGaD
Methohexital—GABRA1—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	0.00025	0.00172	CbGpPWpGaD
Methohexital—GABRG2—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	0.000249	0.00172	CbGpPWpGaD
Methohexital—GABRA1—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	0.000249	0.00171	CbGpPWpGaD
Methohexital—GABRA1—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	0.000247	0.0017	CbGpPWpGaD
Methohexital—GABRA1—SIDS Susceptibility Pathways—CASP3—type 2 diabetes mellitus	0.000247	0.0017	CbGpPWpGaD
Methohexital—GABRA1—Neuronal System—CALM1—type 2 diabetes mellitus	0.000245	0.00169	CbGpPWpGaD
Methohexital—GABRB3—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	0.000242	0.00167	CbGpPWpGaD
Methohexital—GABRG2—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	0.000238	0.00164	CbGpPWpGaD
Methohexital—GABRB3—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	0.000232	0.0016	CbGpPWpGaD
Methohexital—GABRA1—SIDS Susceptibility Pathways—NFKB1—type 2 diabetes mellitus	0.000231	0.00159	CbGpPWpGaD
Methohexital—GABRA1—Neuronal System—PRKCB—type 2 diabetes mellitus	0.00023	0.00158	CbGpPWpGaD
Methohexital—GABRG2—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	0.000228	0.00157	CbGpPWpGaD
Methohexital—GABRA1—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	0.000218	0.0015	CbGpPWpGaD
Methohexital—GABRA1—SIDS Susceptibility Pathways—VEGFA—type 2 diabetes mellitus	0.000209	0.00144	CbGpPWpGaD
Methohexital—GABRA1—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	0.000208	0.00143	CbGpPWpGaD
Methohexital—GABRB3—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	0.0002	0.00138	CbGpPWpGaD
Methohexital—GABRA1—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	0.000199	0.00137	CbGpPWpGaD
Methohexital—GABRB3—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	0.000199	0.00137	CbGpPWpGaD
Methohexital—GABRB3—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	0.000197	0.00136	CbGpPWpGaD
Methohexital—GABRG2—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	0.000196	0.00135	CbGpPWpGaD
Methohexital—GABRG2—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	0.000196	0.00135	CbGpPWpGaD
Methohexital—GABRG2—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	0.000194	0.00134	CbGpPWpGaD
Methohexital—GABRB3—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	0.000191	0.00131	CbGpPWpGaD
Methohexital—GABRG2—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	0.000187	0.00129	CbGpPWpGaD
Methohexital—GABRA1—SIDS Susceptibility Pathways—TNF—type 2 diabetes mellitus	0.00018	0.00124	CbGpPWpGaD
Methohexital—GABRB3—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	0.000178	0.00123	CbGpPWpGaD
Methohexital—GABRG2—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	0.000175	0.00121	CbGpPWpGaD
Methohexital—GABRA1—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	0.000172	0.00118	CbGpPWpGaD
Methohexital—GABRA1—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	0.000171	0.00118	CbGpPWpGaD
Methohexital—GABRA1—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	0.000169	0.00117	CbGpPWpGaD
Methohexital—GABRB3—BDNF signaling pathway—AKT1—type 2 diabetes mellitus	0.000166	0.00114	CbGpPWpGaD
Methohexital—GABRA1—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	0.000164	0.00113	CbGpPWpGaD
Methohexital—GABRB3—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	0.000161	0.00111	CbGpPWpGaD
Methohexital—GABRG2—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	0.000158	0.00109	CbGpPWpGaD
Methohexital—GABRA1—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	0.000153	0.00105	CbGpPWpGaD
Methohexital—GABRB3—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	0.000151	0.00104	CbGpPWpGaD
Methohexital—GABRG2—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	0.000148	0.00102	CbGpPWpGaD
Methohexital—GABRA1—SIDS Susceptibility Pathways—IL6—type 2 diabetes mellitus	0.000145	0.000998	CbGpPWpGaD
Methohexital—GABRA1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	0.000138	0.000952	CbGpPWpGaD
Methohexital—GABRA1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	0.00013	0.000893	CbGpPWpGaD
Methohexital—GABRB3—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	0.00012	0.000824	CbGpPWpGaD
Methohexital—GABRG2—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	0.000117	0.000809	CbGpPWpGaD
Methohexital—GABRA1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	0.000103	0.000707	CbGpPWpGaD
